Lannett Announces CFO Retirement
PHILADELPHIA, May 24, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that the company's chief financial officer (CFO), Martin Galvan, 67, will retire on August 30, 2019, following the planned submission... Biopharmaceuticals, Generics, Personnel Lannett (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2019 Category: Pharmaceuticals Source Type: news

Nektar Announces the Launch of Inheris Biopharma, Inc.
Key Assets will Include NKTR-181, a Novel, First-in-Class, Investigational Opioid New Management Team Includes Jay Galeota as President & Chief Executive Officer, Dr. Joe Stauffer as Chief Medical Officer and George Shiebler as SVP & General Counsel ... Biopharmaceuticals, Personnel Nektar Therapeutics, Inheris Biopharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 23, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
ADELAIDE, Australia, May 22, 2019 -- (Healthcare Sales & Marketing Network) -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved SORILUX® (calcipotriene) Foam, 0.005% in adolescent... Biopharmaceuticals, Dermatology, FDA Mayne Pharma, SORILUX, calcipotriene, plaque psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2019 Category: Pharmaceuticals Source Type: news

Edwards Announces Milestones For Transcatheter Mitral Program
PARIS, May 22, 2019 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regu... Devices, Cardiology, Interventional Edwards Lifesciences, PASCAL , transcatheter valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2019 Category: Pharmaceuticals Source Type: news

Halozyme Announces argenx Has Selected Second Target Under ENHANZE(R) Technology Collaboration And License Agreement
Triggers $10 million milestone payment to Halozyme in the second quarter SAN DIEGO, May 22, 2019 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-deliver... Biopharmaceuticals, Drug Delivery, Licensing Halozyme Therapeutics, argenx , ENHANZE (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 22, 2019 Category: Pharmaceuticals Source Type: news

Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren(R) Gel 1%
DUBLIN, May 21, 2019 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its partner received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application (ANDA... Biopharmaceuticals, Generics, FDA, Product Launch Perrigo, Voltaren, Voltaren Gel, diclofenac (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2019 Category: Pharmaceuticals Source Type: news

Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Company challenges CMS' unexplained and unlawful reversal of its repeated 2012 written authorizations on calculation of Medicaid Rebates for Acthar Gel After extensive efforts to resolve matter, Mallinckrodt seeks Court intervention to ensure that CMS f... Biopharmaceuticals, Reimbursement, Litigation Mallinckrodt, Acthar Gel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2019 Category: Pharmaceuticals Source Type: news

DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
Appoint Drs. David Reardon, Timothy Cloughesy, and Nicholas Butowski VANCOUVER, British Columbia and MENLO PARK, Calif., May 20, 2019 -- (Healthcare Sales & Marketing Network) -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the &q... Biopharmaceuticals, Oncology, Personnel DelMar Pharmaceuticals, VAL-083 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2019 Category: Pharmaceuticals Source Type: news

Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
SAN DIEGO, May 20, 2019 -- (Healthcare Sales & Marketing Network) -- Reneo Pharmaceuticals, a clinical stage pharmaceutical company, today announced that it has completed a $50 million Series A financing to develop therapies for diseases associated with d... Biopharmaceuticals, Venture Capital Reneo Pharmaceuticals, mitochondrial diseases (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 20, 2019 Category: Pharmaceuticals Source Type: news

UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
NAYZILAM® (midazolam) nasal spray CIV is a nasally administered benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct fr... Biopharmaceuticals, Neurology, FDA UCB , NAYZILAM, midazolam, epilepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 20, 2019 Category: Pharmaceuticals Source Type: news

Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss
SHEFFIELD, England, May 20, 2019 -- (Healthcare Sales & Marketing Network) -- Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1.4 million in seed fun... Regenerative Medicine, Venture Capital, Personnel Rinri Therapeutics, neuropathic, sensorineural hearing loss (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 20, 2019 Category: Pharmaceuticals Source Type: news

Dale(R) Introduces New Hold-n-Place(R) Catheter Securement Products
Proprietary Devices Provide Trusted Securement for Catheters of Any Size FRANKLIN, Mass., May 17, 2019 -- (Healthcare Sales & Marketing Network) -- Dale Medical Products, Inc. (Dale), the company known for its high quality, patient-friendly medical dev... Devices, Product Launch Dale Medical Products, Hold-n-Place, Catheter Securement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2019 Category: Pharmaceuticals Source Type: news

U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
GATTEX is the only glucagon-like peptide-2 (GLP-2) analog approved that improves intestinal absorption in patients with SBS who are dependent on parenteral support (PS)¹ GATTEX has been shown to reduce PS volume and to help some children with SBS w... Biopharmaceuticals, Gastroenterology, FDA Takeda Pharmaceuticals, GATTEX, teduglutide, Short Bowel Syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2019 Category: Pharmaceuticals Source Type: news

Soliton Provides FDA Update and Addresses Recent Anonymous Article
HOUSTON, May 17, 2019 -- (Healthcare Sales & Marketing Network) -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Te... Devices, Dermatology, FDA Soliton, Rapid Acoustic Pulse (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2019 Category: Pharmaceuticals Source Type: news

Exact Sciences Presents New Data Reinforcing Performance of Cologuard(R)
Researchers to Present Real-World Findings at Digestive Disease Week® 2019 SAN DIEGO, May 17, 2019 -- (Healthcare Sales & Marketing Network) -- New research from Exact Sciences and Mayo Clinic demonstrates the ability of Cologuard to both screen la... Diagnostics, Gastroenterology, Oncology Exact Sciences, Cologuard, colorectal cancer screening (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2019 Category: Pharmaceuticals Source Type: news

Proton Therapy Center in Prague Becomes First Czech Clinic to Order RayStation
STOCKHOLM, May 17, 2019 -- (Healthcare Sales & Marketing Network) -- Proton Therapy Center Czech (Prague PTC) is the only one of its kind in Czechia, and it has selected RayStation® as its sole treatment planning system. This is RaySearch's first orde... Devices, Oncology RaySearch Laboratories, RayStation, treatment planning, proton therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2019 Category: Pharmaceuticals Source Type: news

Pulmatrix Announces Leadership Change
LEXINGTON, Mass., May 16, 2019 -- (Healthcare Sales & Marketing Network) -- Pulmatrix, Inc. (NASDAQ: PULM) announces today that Dr. Robert Clarke has stepped down as Chief Executive Officer. Ted Raad will immediately transition from his current role as C... Biopharmaceuticals, Drug Delivery, Personnel Pulmatrix, iSPERSE, Pulmazole (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2019 Category: Pharmaceuticals Source Type: news

GenePOC Obtains FDA Clearance for its GenePOC(TM) Carba Test in the US
GenePOC announces FDA clearance of its molecular diagnostic test for the detection and differentiation of the five most frequent gene sequences associated with carbapenem-non-susceptibility QUÉBEC, Canada, May 16, 2019 -- (Healthcare Sales & Mark... Diagnostics, FDA GenePOC, Debiopharm, revogene, Carba assay, carbapenem-producing organisms (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 16, 2019 Category: Pharmaceuticals Source Type: news

IO Biotech Initiates Global Phase 2 Portion of Clinical Trial For T-win(R) Immunotherapy in Non-small Cell Lung Cancer
COPENHAGEN, Denmark, May 15, 2019 -- (Healthcare Sales & Marketing Network) -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies based on its proprietary T-win® technology, announced the i... Biopharmaceuticals, Oncology IO Biotech, NSCLC, Immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2019 Category: Pharmaceuticals Source Type: news

Boehringer Ingelheim announces resolution of Cyltezo(R) patent litigation
Settlement provides Boehringer Ingelheim with a clear path to secure patient access to Cyltezo® in the U.S. License period places Boehringer Ingelheim's biosimilar among the first to compete with Humira® in the U.S. RIDGEFIELD, Conn., May 14,... Biopharmaceuticals, Litigation, Licensing Boehringer Ingelheim, AbbVie, Cyltezo, adalimumab, biosimilar, Humira (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2019 Category: Pharmaceuticals Source Type: news

AbbVie Resolves HUMIRA(R) (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
NORTH CHICAGO, Ill., May 14, 2019 -- (Healthcare Sales & Marketing Network) -- AbbVie (NYSE: ABBV) announced that it has resolved U.S. HUMIRA (adalimumab) litigation with Boehringer Ingelheim (BI). Under the terms of the resolution, AbbVie will grant BI a... Biopharmaceuticals, Litigation, Licensing AbbVie, Boehringer Ingelheim, HUMIRA, adalimumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2019 Category: Pharmaceuticals Source Type: news

Brain imaging AI leader icometrix raises $18 million in new funding
Company's technology will transform care for patients with brain disorders and injuries LEUVEN, Belgium and GENEVA and BOSTON, May 14, 2019 -- (Healthcare Sales & Marketing Network) -- icometrix, the global expert in brain imaging Artificial Intelligen... Devices, Neurology, Venture Capital icometrix , icobrain software (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2019 Category: Pharmaceuticals Source Type: news

John Fletcher Named Strategic Advisor to Micro Medical Solutions
As MMS prepares for approval of their pivotal clinical trial of the company's flagship MicroStent device, one of healthcare's top growth experts will help shape the company's future WILMINGTON, Mass., May 14, 2019 -- (Healthcare Sales & Marketing Networ... Devices, Interventional, Personnel Micro Medical Solutions, MicroStent, peripheral artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2019 Category: Pharmaceuticals Source Type: news

CrossRoads Extremity Systems and HealthpointCapital Announce Merger Agreement
Investment to support growth of CrossRoads' Active Stabilization® platform MEMPHIS, Tenn., May 14, 2019 -- (Healthcare Sales & Marketing Network) -- CrossRoads® Extremity Systems, a privately held medical device company and leading innovator in... Devices, Orthopaedic, Mergers & Acquisitions CrossRoads Extremity Systems, Active Stabilization, EcoSMART, Instrument Service (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2019 Category: Pharmaceuticals Source Type: news

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
PALO ALTO, Calif. and SINGAPORE, May 14, 2019 -- (Healthcare Sales & Marketing Network) -- At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the V... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2019 Category: Pharmaceuticals Source Type: news

AEON Biopharma Appoints BOTOX(R) Therapeutic Head as President and Chief Executive Officer
Dynamic Industry Veteran Led Multi-Billion Dollar Therapeutic Neurotoxin Portfolio NEWPORT BEACH, Calif., May 13, 2019 -- (Healthcare Sales & Marketing Network) -- ALPHAEON Corporation announced today that its Board of Directors has named Marc Forth as... Biopharmaceuticals, Personnel AEON Biopharma, ALPHAEON, botulinum toxin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, Allergy, and Rheumatology, to Board of Directors
BOSTON, May 13, 2019 -- (Healthcare Sales & Marketing Network) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF)... Biopharmaceuticals, Personnel Proteostasis Therapeutics, transmembrane conductance regulator, cystic fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

Smith and Nephew launches new FLOW 90(TM) Wand at ISAKOS joining its innovative collection of COBLATION(TM) technology and shoulder repair portfolios
LONDON, May 13, 2019 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology. Designed for use in the s... Devices, Orthopaedic, Product Launch Smith & Nephew, WEREWOLF, FLOW 90 Wand, COBLATION System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

Check-Cap Announces Second Trial Site Joins Ongoing U.S. Pilot Study of C-Scan(R)
Mayo Clinic joins New York University in pilot study of C-Scan® in the U.S. ISFIYA, Israel, May 13, 2019 -- (Healthcare Sales & Marketing Network) -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW),... Devices, Gastroenterology Check-Cap, C-Scan, ingestible capsule, colorectal cancer screening (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
Strategic investment signals positive response of healthcare community to Theranica's new approach to migraine management NETANYA, Israel, May 13, 2019 -- (Healthcare Sales & Marketing Network) -- Theranica today announced OMRON VENTURES has joined its... Devices, Neurology, Venture Capital Theranica Bio-Electronics, Nerivio Migra, neuromodulation, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

FDA Grants First Ever Clearance For Six-Lead Personal ECG Device
KardiaMobile® is the Only Personal ECG that Delivers Multi-Dimensional Insight into a Patient's Heart MOUNTAIN VIEW, Calif., May 13, 2019 -- (Healthcare Sales & Marketing Network) -- AliveCor, the leader in FDA-cleared consumer electrocardiogram te... Devices, Monitoring, Cardiology, FDA AliveCor , electrocardiogram, KardiaMobile, personal ECG (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 13, 2019 Category: Pharmaceuticals Source Type: news

Rani Therapeutics Hires First CFO
SAN JOSE, Calif., May 10, 2019 -- (Healthcare Sales & Marketing Network) -- Rani Therapeutics, creator of the robotic RaniPill™ capsule designed to replace injections of large drug molecules including peptides, proteins, and antibodies, today announced th... Devices, Drug Delivery, Personnel Rani Therapeutics, RaniPill (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2019 Category: Pharmaceuticals Source Type: news

PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE
SALT LAKE CITY, May 10, 2019 -- (Healthcare Sales & Marketing Network) -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today data from two pilot studies on ... Regenerative Medicine, Wound Care PolarityTE, SkinTE, diabetic foot ulcers (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2019 Category: Pharmaceuticals Source Type: news

NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA
LUND, Sweden, May 10, 2019 -- (Healthcare Sales & Marketing Network) -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the US Food and Drug Administration, FDA, has approved NeuroVive's IND (Investigational New Dru... Biopharmaceuticals, Neurology, FDA NeuroVive Pharmaceutical, NeuroSTAT, traumatic brain injury (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2019 Category: Pharmaceuticals Source Type: news

Varian Acquires CyberHeart
Company Adds Technology for Cardiac Radioablation to Its Radiation Medicine Portfolio PALO ALTO, Calif., May 9, 2019 -- (Healthcare Sales & Marketing Network) -- Acquisition Key Highlights The CyberHeart acquisition secures significant intellectu... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, CyberHeart, cardiac radioablation, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

MiMedx Appoints Timothy R. Wright as Chief Executive Officer
Healthcare Industry Veteran to Lead Next Phase of MiMedx MARIETTA, Ga., May 9, 2019 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound c... Devices, Wound Care, Personnel MiMedx Group, PURION, placental tissue, allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies MARLBOROUGH, Mass., May 9, 2019 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) today announced that it has entered into a d... Devices, Orthopaedic, Neurosurgery, Mergers & Acquisitions Boston Scientific, Vertiflex, Superion System, lumbar spinal stenosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China
PALO ALTO, Calif. and JINAN, China, May 9, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton therapy clinical a... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

Evox Therapeutics Expands Leadership Team With the Appointment of Two Experienced Life Sciences Executives
OXFORD, England, May 9, 2019 -- (Healthcare Sales & Marketing Network) -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce the appointments of Bo Kara as VP Process Development and Simon Dew a... Biopharmaceuticals, Personnel Evox Therapeutics, exosomes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier
BOCA RATON, Fla., May 8, 2019 -- (Healthcare Sales & Marketing Network) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement ... Devices, Oncology, Dermatology, Group Purchasing Sensus Healthcare, superficial radiation therapy, skin cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news

Glenmark Pharmaceuticals Announces Results from a Phase 3 Study of Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, in Patients Aged 6 to Under 12 Years
The study of Ryaltris (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg] nasal spray) in pediatric patients aged 6 to under 12 years of age met its primary endpoint, and results were consistent with extensive clinical trial experience wit... Biopharmaceuticals Glenmark Pharmaceuticals, Ryaltris, olopatadine, seasonal allergic rhinitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news

ReNeuron Provides Business Update and Results Notification
Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete LONDON, May 8, 2019 -- (Healthcare Sales & Marketing Network) -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, announced a year-end... Regenerative Medicine, Ophthalmology, Neurology ReNeuron Group, retinitis pigmentosa, stroke, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo Announces [Fam-] Trastuzumab Deruxtecan Demonstrated Clinically Meaningful Response in Patients with Refractory HER2 Positive Metastatic Breast Cancer, a Population with High Unmet Need
Pivotal phase 2 DESTINY-Breast01 trial met primary endpoint, supporting global regulatory submission plan to start in first half of fiscal year 2019 TOKYO and MUNICH and BASKING RIDGE, N.J., May 8, 2019 -- (Healthcare Sales & Marketing Network) -- Daii... Biopharmaceuticals, Oncology Daiichi Sankyo, AstraZeneca, trastuzumab deruxtecan, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news

Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device
Comaneci - the only non-vessel-occluding temporary intracranial coiling embolization assist device YOKNEAM, Israel, May 7, 2019 -- (Healthcare Sales & Marketing Network) -- Rapid Medical, a company focused on the development of next generation neurovas... Devices, Interventional, FDA Rapid Medical, Comaneci, Coil Embolization, cerebral aneurysm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 7, 2019 Category: Pharmaceuticals Source Type: news

Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Only biologic approved in the EU for severe asthma with type 2 inflammation, as characterized by raised blood eosinophils and/or raised fractional exhaled nitric oxide (FeNO) In clinical trials, Dupixent improved lung function and quality of life, and r... Biopharmaceuticals, Regulatory Regeneron Pharmaceuticals, Sanofi, Dupixent, dupilumab, asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 7, 2019 Category: Pharmaceuticals Source Type: news

Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
World's First Smartphone-Compatible Implantable Heart Monitor, Abbott's Confirm Rx™ Icm Offers More Accurate Detection Of Heart Rhythm Disorders ABBOTT PARK, Ill., May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Abbott today announced the laun... Devices, Monitoring, Cardiology, Product Launch Abbott, Confirm Rx, insertable cardiac monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 6, 2019 Category: Pharmaceuticals Source Type: news

Spiral Therapeutics Closes Series A Financing Totaling $5.6 Million
BRISBANE, Calif., May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Spiral Therapeutics, a clinical stage pharmaceutical company delivering therapies for hearing loss, today announced the final closing of its Series A financing, bringing the total ... Biopharmaceuticals, Venture Capital Spiral Therapeutics, hearing loss (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 6, 2019 Category: Pharmaceuticals Source Type: news

Fresenius Medical Care North America Announces Leadership Additions Following NxStage Merger
New Leadership and Team to Further Company's Commitment to Home Therapies WALTHAM, Mass., May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and s... Devices, Personnel Fresenius, NxStage Medical, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 6, 2019 Category: Pharmaceuticals Source Type: news

Halozyme Names Dr. Alison A. Armour As Senior Vice President of Research and Development
SAN DIEGO, May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of biotechnology and pharmaceuti... Biopharmaceuticals, Oncology, Personnel Halozyme Therapeutics, pegvorhyaluronidase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 6, 2019 Category: Pharmaceuticals Source Type: news

Heska Corporation Names Chief Financial Officer to Enhance Executive Team
LOVELAND, Colo., May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Heska Corporation (NASDAQ: HSKA ; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced the promotion o... Biopharmaceuticals, Diagnostics, Veterinary, Personnel Heska, Core Companion Animal Health (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 6, 2019 Category: Pharmaceuticals Source Type: news